Status:
COMPLETED
Validation of a Non-invasive Hemodynamic Monitor (NexFin) in Pregnant Women
Lead Sponsor:
Oslo University Hospital
Conditions:
Hemodynamic Changes in Pregnancy
Eligibility:
FEMALE
18-50 years
Brief Summary
Blood pressure and cardiac output can be measured invasively in pregnant women. Non-invasive monitoring devices are desirable, but until now, no equipment has proven validity. This study aims at valid...
Detailed Description
Validation will be a direct beat-to-beat comparison of data from NexFin and the invasive measurements of blood pressure and calibrated cardiac output as an integrated part of LiDCO Plus. Both comparis...
Eligibility Criteria
Inclusion
- Healthy singleton pregnancies at term scheduled for cesarean delivery
Exclusion
- Twins, or multiple gestation, pre-eclampsia, gestational hypertension
- Reynaud phenomenon
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01861132
Start Date
May 1 2013
End Date
February 1 2014
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, 0424